Yasmin Hilliam

<i>Pseudomonas aeruginosa</i>adaptation and diversification in the non-cystic fibrosis bronchiectasis lung

Yasmin Hilliam, Matthew Moore, Iain L. Lamont et al. · European Respiratory Journal · 2017 · 100 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Persistence and evolution of <i>Pseudomonas aeruginosa</i> following initiation of highly effective modulator therapy in cystic fibrosis

Catherine R. Armbruster, Yasmin Hilliam, Anna C. Zemke et al. · mBio · 2024 · 44 citations · Full text

Pharmacy, Infectious Diseases, Respiratory Therapy +13

Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy

Yasmin Hilliam, Catherine R. Armbruster, Glenn J. Rapsinski et al. · Microbiology Spectrum · 2024 · 23 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Elexacaftor–tezacaftor–ivacaftor decreases pseudomonas abundance in the sinonasal microbiome in cystic fibrosis

Anna C. Zemke, Yasmin Hilliam, Amanda L. Stapleton et al. · International Forum of Allergy & Rhinology · 2023 · 17 citations · Full text

Life Sciences, Microbiology, Allergy +16

Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis

S. Atteih, Catherine R. Armbruster, Yasmin Hilliam et al. · Pediatric Pulmonology · 2024 · 16 citations · Full text

Life Sciences, Immunology, Internal Medicine +17